Who invested in Avelos Therapeutics?
Avelos Therapeutics's investors include Mirae Asset Venture Investment and Shinhan Capital.

Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2024, from 1 source
Avelos Therapeutics's investors include Mirae Asset Venture Investment and Shinhan Capital.
Avelos Therapeutics has raised $12M across 1 round since 2024.
Avelos Therapeutics's most recent round was a Series B of $12M in May 2024.
Its most recent round, $12M in May 2024, is also its largest on record.
Avelos Therapeutics's first round on record, in May 2024, was backed by Mirae Asset Venture Investment and Shinhan Capital.
Avelos Therapeutics's latest named round is a Series B, in May 2024.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.